These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 23835352)
1. Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration. Del Re AC; Gordon AJ; Lembke A; Harris AH Addict Sci Clin Pract; 2013 Jul; 8(1):12. PubMed ID: 23835352 [TBL] [Abstract][Full Text] [Related]
2. Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness. Harris AH; Bowe T; Hagedorn H; Nevedal A; Finlay AK; Gidwani R; Rosen C; Kay C; Christopher M Addict Sci Clin Pract; 2016 Sep; 11(1):15. PubMed ID: 27633982 [TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence. Harris AH; Oliva E; Bowe T; Humphreys KN; Kivlahan DR; Trafton JA Psychiatr Serv; 2012 Jul; 63(7):679-85. PubMed ID: 22549276 [TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Harris AH; Kivlahan DR; Bowe T; Humphreys KN Psychiatr Serv; 2010 Apr; 61(4):392-8. PubMed ID: 20360279 [TBL] [Abstract][Full Text] [Related]
5. Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration. Taylor E; Timko C; Harris AHS; Yu M; Finlay AK Addict Sci Clin Pract; 2019 Jan; 14(1):1. PubMed ID: 30602392 [TBL] [Abstract][Full Text] [Related]
6. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions. Williams EC; Matson TE; Harris AHS Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686 [TBL] [Abstract][Full Text] [Related]
7. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses. Rubinsky AD; Chen C; Batki SL; Williams EC; Harris AH J Psychiatr Res; 2015 Oct; 69():150-7. PubMed ID: 26343607 [TBL] [Abstract][Full Text] [Related]
8. Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study. Iheanacho T; Issa M; Marienfeld C; Rosenheck R Drug Alcohol Depend; 2013 Sep; 132(1-2):122-6. PubMed ID: 23434041 [TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of alcohol use disorders: seventy-five years of progress. Zindel LR; Kranzler HR J Stud Alcohol Drugs Suppl; 2014; 75(17):79-88. PubMed ID: 24565314 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders. Helton SG; Lohoff FW Psychiatry Res; 2015 Dec; 230(2):121-9. PubMed ID: 26455758 [TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. Harris AHS; Ellerbe L; Reeder RN; Bowe T; Gordon AJ; Hagedorn H; Oliva E; Lembke A; Kivlahan D; Trafton JA Psychol Serv; 2013 Nov; 10(4):410-419. PubMed ID: 23356858 [TBL] [Abstract][Full Text] [Related]
12. Rates of prescription orders for United States active duty service members diagnosed with alcohol use disorder. Peters ZJ; Kincaid MW; Greenberg JG; Quah RF; Curry JC Subst Abus; 2021; 42(4):638-645. PubMed ID: 32870103 [No Abstract] [Full Text] [Related]
13. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety. Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397 [TBL] [Abstract][Full Text] [Related]
14. Alcohol-related and mental health care for patients with unhealthy alcohol use and posttraumatic stress disorder in a National Veterans Affairs cohort. Chen JA; Owens MD; Browne KC; Williams EC J Subst Abuse Treat; 2018 Feb; 85():1-9. PubMed ID: 29291765 [TBL] [Abstract][Full Text] [Related]
15. MOVE: weight management program across the Veterans Health Administration: patient- and facility-level predictors of utilization. Del Re AC; Maciejewski ML; Harris AH BMC Health Serv Res; 2013 Dec; 13():511. PubMed ID: 24325730 [TBL] [Abstract][Full Text] [Related]
16. Veterans' Service Utilization Patterns After Alcohol and Opioid Detoxification in VHA Care. Timko C; Gupta S; Schultz N; Harris AH Psychiatr Serv; 2016 Apr; 67(4):460-4. PubMed ID: 26766752 [TBL] [Abstract][Full Text] [Related]
17. Geographic differences in receipt of addictions treatment in a national sample of patients with alcohol use disorders from the U.S. Veterans Health Administration. Edmonds AT; Bensley KM; Hawkins EJ; Williams EC Subst Abus; 2021; 42(4):559-568. PubMed ID: 32821028 [No Abstract] [Full Text] [Related]
18. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population. Walker JR; Korte JE; McRae-Clark AL; Hartwell KJ J Stud Alcohol Drugs; 2019 Sep; 80(5):572-577. PubMed ID: 31603760 [TBL] [Abstract][Full Text] [Related]
19. Comparing alternative specifications of quality measures: access to pharmacotherapy for alcohol use disorders. Fernandes-Taylor S; Harris AH J Subst Abuse Treat; 2012 Jan; 42(1):102-7. PubMed ID: 21839604 [TBL] [Abstract][Full Text] [Related]
20. Predictors of injury-related and non-injury-related mortality among veterans with alcohol use disorders. Fudalej S; Bohnert A; Austin K; Barry K; Blow F; Ilgen M Addiction; 2010 Oct; 105(10):1759-66. PubMed ID: 20670347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]